Insider Transactions in Q1 2022 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2022
|
Helen Torley PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,892
-1.16%
|
$234,328
$34.43 P/Share
|
|
Feb 15
2022
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,092
+2.16%
|
-
|
|
Feb 15
2022
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-4.57%
|
$14,722
$34.43 P/Share
|
|
Feb 15
2022
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,255
+11.69%
|
-
|
|
Feb 15
2022
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,170
-0.67%
|
$39,780
$34.43 P/Share
|
|
Feb 15
2022
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.91%
|
-
|
|
Feb 14
2022
|
Helen Torley PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,125
-2.54%
|
$499,125
$33.64 P/Share
|
|
Feb 14
2022
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,729
+4.6%
|
-
|
|
Feb 14
2022
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-4.94%
|
$14,091
$33.64 P/Share
|
|
Feb 14
2022
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,256
+12.68%
|
-
|
|
Feb 14
2022
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,995
-1.15%
|
$65,835
$33.64 P/Share
|
|
Feb 14
2022
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,771
+3.23%
|
-
|
|
Feb 12
2022
|
Helen Torley PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,266
-2.95%
|
$587,044
$34.2 P/Share
|
|
Feb 12
2022
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,795
+5.31%
|
-
|
|
Feb 12
2022
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-6.41%
|
$17,204
$34.2 P/Share
|
|
Feb 12
2022
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+14.95%
|
-
|
|
Feb 12
2022
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,725
-1.6%
|
$92,650
$34.2 P/Share
|
|
Feb 12
2022
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,883
+4.43%
|
-
|
|
Feb 10
2022
|
Helen Torley PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,598
-2.92%
|
$564,332
$34.94 P/Share
|
|
Feb 10
2022
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,282
+5.22%
|
-
|
|
Feb 10
2022
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-13.6%
|
$34,850
$34.94 P/Share
|
|
Feb 10
2022
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,503
+24.93%
|
-
|
|
Feb 10
2022
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,992
-1.81%
|
$101,728
$34.94 P/Share
|
|
Feb 10
2022
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,133
+4.7%
|
-
|